Position in UTHR
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$319,616
New position
Shares Held
539
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Frec Markets, Inc. holds $1,915,041 across 7 Drug Manufacturers - Specialty & Generic names. UTHR ranks #2 (16.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
3,723 | $490,468 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
539 | $319,616 | |
| 3 | VTRS |
Viatris Inc
|
19,415 | $262,296 | |
| 4 | ZTS |
Zoetis Inc.
|
2,065 | $244,103 | |
| 5 | DERM |
Journey Medical Corp
|
50,500 | $236,845 | |
| 6 | TAK |
Takeda Pharmaceutical Co Ltd
|
11,530 | $213,535 | |
| 7 | HLN |
Haleon plc
|
14,803 | $148,178 |
All Filings in UTHR
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $319,616 | 539 | Shares | Defined | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||